FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026403140> ?p ?o ?g. }

• W2026403140 endingPage "31234" @default.
• W2026403140 startingPage "31230" @default.
• W2026403140 abstract "Ral proteins constitute a family of small GTPases that can be activated by Ras in cells. In the GTP-bound state, Ral proteins bind to RalBP1, a GTPase-activating protein for CDC42 and Rac GTPases. We have used the two-hybrid system in yeast to clone a cDNA for a novel ∼85-kDa protein that can bind to an additional site on RalBP1. This newly identified protein contains an Eps homology (EH) domain, which was first detected in the epidermal growth factor (EGF) receptor substrate Eps15. Recently, the EH domain of Eps15 has been shown to bind to proteins containing an asparagine-proline-phenylalanine motif. Moreover, EH domains have been found in proteins involved in endocytosis and/or actin cytoskeleton regulation. The RalBP1 associated Eps-homology domain protein, Reps1, is tyrosine-phosphorylated in response to EGF stimulation of cells. In addition, Reps1 has the capacity to form a complex with the SH3 domains of the adapter proteins Crk and Grb2, which may link Reps1 to an EGF-responsive tyrosine kinase. Thus, Reps1 may coordinate the cellular actions of activated EGF receptors and Ral-GTPases. Ral proteins constitute a family of small GTPases that can be activated by Ras in cells. In the GTP-bound state, Ral proteins bind to RalBP1, a GTPase-activating protein for CDC42 and Rac GTPases. We have used the two-hybrid system in yeast to clone a cDNA for a novel ∼85-kDa protein that can bind to an additional site on RalBP1. This newly identified protein contains an Eps homology (EH) domain, which was first detected in the epidermal growth factor (EGF) receptor substrate Eps15. Recently, the EH domain of Eps15 has been shown to bind to proteins containing an asparagine-proline-phenylalanine motif. Moreover, EH domains have been found in proteins involved in endocytosis and/or actin cytoskeleton regulation. The RalBP1 associated Eps-homology domain protein, Reps1, is tyrosine-phosphorylated in response to EGF stimulation of cells. In addition, Reps1 has the capacity to form a complex with the SH3 domains of the adapter proteins Crk and Grb2, which may link Reps1 to an EGF-responsive tyrosine kinase. Thus, Reps1 may coordinate the cellular actions of activated EGF receptors and Ral-GTPases. The Ral-GTPases, RalA and RalB, form a family of Ras-related GTP-binding proteins (1Chardin P. Tavitian A. EMBO J. 1986; 5: 2203-2208Crossref PubMed Scopus (174) Google Scholar). Like all GTPases, Ral proteins cycle between the active GTP bound and inactive GDP bound states. Activation of Ral proteins occurs upon interaction with a Ral-specific guanine nucleotide exchange factor (for review, see Ref. 2Feig L.A. Urano T. Cantor S. Trends Biochem. Sci. 1996; 21: 438-441Abstract Full Text PDF PubMed Scopus (179) Google Scholar). This promotes the release of GDP from Ral, allowing activating GTP to take its place. Deactivation takes place when bound GTP is hydrolyzed back to GDP upon interaction of Ral with a specific GTPase-activating protein, Ral-GAP (3Emkey R. Freedman S. Feig L.A. J. Biol. Chem. 1991; 266: 9703-9706Abstract Full Text PDF PubMed Google Scholar). It is likely that Ral proteins act as molecular switches that become active in response to specific upstream signals and then alter the activities of specific downstream target proteins. A series of recent findings support the idea that Ras proteins are important upstream activators of Ral proteins. In particular, it has been shown that active GTP-bound Ras binds to (4Hofer F. Fields S. Schneider C. Martin G.S. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 11089-11093Crossref PubMed Scopus (254) Google Scholar, 5Kikuchi A. Demo S.D. Ye Z.-H. Chen Y.W. Williams L.T. Mol. Cell. Biol. 1994; 14: 7483-7491Crossref PubMed Scopus (244) Google Scholar, 6Spaargaren M. Bischoff J.R. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 12609-12613Crossref PubMed Scopus (249) Google Scholar) and activates (7Urano T. Emkey R. Feig L.A. EMBO J. 1996; 16: 810-816Crossref Scopus (300) Google Scholar) Ral-specific guanine nucleotide exchange factors, which then activate Ral proteins in cells. Thus, activation of Ral-GTPases appears to constitute a distinct downstream signaling pathway from Ras (for review, see Ref. 2Feig L.A. Urano T. Cantor S. Trends Biochem. Sci. 1996; 21: 438-441Abstract Full Text PDF PubMed Scopus (179) Google Scholar). Studies are beginning to reveal how Ral proteins contribute to Ras signaling. Overexpression of Ral-GDS (8White M.A. Vale T. Camonis J.H. Schaefer E. Wigler M.H. J. Biol. Chem. 1996; 271: 16439-16442Abstract Full Text Full Text PDF PubMed Scopus (216) Google Scholar) or constitutively active Ral (7Urano T. Emkey R. Feig L.A. EMBO J. 1996; 16: 810-816Crossref Scopus (300) Google Scholar) can enhance cellular transformation induced by Ras, and expression of a dominant negative form of Ral can suppress Ras-induced transformation (7Urano T. Emkey R. Feig L.A. EMBO J. 1996; 16: 810-816Crossref Scopus (300) Google Scholar). This phenomenon may occur, in part, by a contribution of Ral to fos gene activation (9Okazaki M. Kishida S. Hinoi T. Hasegawa T. Tamada M. Kataoka T. Kikuchi A. Oncogene. 1997; 14: 515-521Crossref PubMed Scopus (56) Google Scholar). Two signaling molecules have been identified that may be affected by Ral protein activity. The first is phospholipase D (PLD), 1The abbreviations used are: PLD, phospholipase D; GST, glutathione S-transferase; PAGE, polyacrylamide gel electrophoresis; RalBP1, Ral-binding protein 1; Reps1, RalBP1-associated Eps homology domain protein; EH, Eps homology; RACE, rapid amplification of cDNA ends; Ral-GDS, Ral-GDP dissociation stimulator; aa, amino acids. which converts phosphatidylcholine to phosphatidic acid. Phosphatidic acid is itself biologically active, but can also be rapidly converted to diacylglycerol, which can then activate protein kinase C isoforms. It is thought that PLD1 is constitutively associated with the N terminus of Ral proteins (10Jiang H. Luo J.-Q. Urano T. Lu Z. Foster D.A. Feig L.A. Nature. 1995; 378: 409-412Crossref PubMed Scopus (247) Google Scholar, 11Luo J.-Q. Liu X. Hammond S.M. Colley W.C. Feig L.A. Frohman M.A. Morris A.J. Foster D.A. Biochem. Biophys. Res. Commun. 1997; 235: 854-859Crossref PubMed Scopus (79) Google Scholar). Upon Ral activation by Ras, PLD appears to be targeted to a specific signaling complex where its catalytic activity may be elevated by Arf or Rho family GTPases (for review, see Ref.12Exton J.H. J. Biol. Chem. 1997; 272: 15579-15582Abstract Full Text Full Text PDF PubMed Scopus (285) Google Scholar). A second target of Ral may be RalBP1 (also called RLIP or RLP) (13Cantor S. Urano T. Feig L.A. Mol Cell. Biol. 1995; 15: 4578-4584Crossref PubMed Scopus (261) Google Scholar, 14Jullien-Flores V. Dorseuil O. Romero F. Letourneur F. Saragosti S. Berger R. Tavitian A. Gacon G. Camonis J.H. J. Biol. Chem. 1995; 270: 22473-22477Abstract Full Text Full Text PDF PubMed Scopus (289) Google Scholar, 15Park S.H. Weinberg R.A. Oncogene. 1995; 11: 2349-2355PubMed Google Scholar). This protein was identified by its ability to bind specifically to active GTP-bound Ral. RalBP1 has been shown to be a GAP for CDC42 and Rac, Ras-related GTPases that influence the actin cytoskeleton and the Jun kinase signal transduction pathway (16Ridley A.J. Curr. Opin. Genet. Dev. 1995; 5: 24-30Crossref PubMed Scopus (153) Google Scholar). In this paper, we identify another potential binding partner for RalBP1. This protein has an Eps homology (EH) domain and becomes tyrosine-phosphorylated in response to EGF signaling. Thus,RalBP1 associated Eps domain-containing protein (Reps1) may mediate an additional function of RalBP1, and therefore Ral, in cells. For two-hybrid screening, RalBP1 cDNA was subcloned as a fusion protein with the DNA binding domain of Gal4, into pAS-CY2 (17Durfee T. Becherer K. Chen P.-L. Yeh S.-H. Yang Y. Kilourn A.E. Lee W.-H. Elledge S.J. Genes Dev. 1993; 7: 555-569Crossref PubMed Scopus (1300) Google Scholar). A mouse cDNA library, derived from a differentiated C2C12 muscle cell line and expressed as fusion proteins with the activation domain of GAl4 in pACT, was kindly provided by Dr. Amy Yee (Tufts Medical School) (18Tevosian S.G. Shih H.H. Mendelson K.G. Sheppard K.A. Paulson K.E. Yee A.S. Genes Dev. 1997; 11: 383-396Crossref PubMed Scopus (129) Google Scholar). The Saccharomyces cerevisiae Y190 (MATa gal4 gal80 his3 trp1–901 ade2–101 ura3–52 leu2–3, 112 URA3:: GAL-lacZ LYS2::GAL-HIS3, cyhr) strain, expressing a GAL4 DNA-binding domain/Ral-BP1 fusion protein, was transformed with the pACT library, and 2.3 × 106 primary transformants were selected for growth on medium lacking leucine, tryptophan, and histidine and containing 30 mm 3-aminotriazole. The plates were incubated at 30 °C for 3 days. Surviving yeast colonies were transferred to nitrocellulose and laid onto minimal media plates containing 5-bromo-4-chloro-3-indolyl-β-d-galactoside and screened for expression of β-galactosidase, by incubation at 30 °C for 1 to 2 days. Blue coloration of a colony was indicative of a positive interaction. His+ LacZ+ colonies were rescued from the plate and grown in selective media. Plasmid DNA was recovered and introduced by electroporation into the leucine deficient Escherichia colistrain, KC8. Transformants were plated on minimal media lacking leucine so that only transformants carrying the library plasmid grew. Positives were tested for target specificity by re-transformation into the reporter strain Y190 alone, in conjunction with the RalBP1-Gal4 DNA-binding domain fusion, or with different Gal4 DNA-binding domain fusions. Only library plasmids that did not activate marker expression on their own or in the presence of a negative control construct, SNF1, were analyzed further. Additional mouse Reps cDNAs were isolated from an oligo(dT) and randomly primed mouse testis library (CLONTECH) by DNA hybridization, using the ∼500-base pair Reps1 clone isolated from the two-hybrid system as a probe. The 5′-end of the cDNA (last 5 codons plus 5′-untranslated region) was then cloned by 5′-RACE (rapid amplification of cDNA ends), using a mouse brain cDNA library as template and terminal deoxynucleotidyltransferase to create poly(C) 5′-ends for primer annealing with a poly(G) primer (containing anEcoRI site at the 5′-end). The entire coding sequence for Reps1 was cloned into pBSK. The sequence of Reps1 cDNA was determined on both strands by the dideoxy chain termination technique, using multiple cDNA clones and subclones. GST-Reps1 (599–743) was generated by subcloning the partial cDNA isolated from the two-hybrid system into pGEX3. Full-length RalBP1 and fragments of it were expressed with N-terminal Myc epitope tags by cloning RalBP1 cDNAs into pJ3M. Full-length RalBP1 was cloned as a BamHI-KpnI fragment. RalBP1 (aa 1–500) was cloned as aBamHI-EcoRI fragment, while RalBP1 (aa 200–647) was cloned as a BglII fragment. Glu-tagged RalBP1 construction was described previously (13Cantor S. Urano T. Feig L.A. Mol Cell. Biol. 1995; 15: 4578-4584Crossref PubMed Scopus (261) Google Scholar). Myc-tagged Reps was generated by cloning full-length Reps from pBSK into pJ3M as anEcoRI fragment. COS-7 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% iron-enriched calf serum (HyClone) at 37 °C in 5% CO2. Cells were plated at a density of ∼5 × 105cells/60-mm plate one day before transfection. pMT3 (19Swick A.G. Janicot M. Cheneval-Kastelic T. McLenithan J.C. Lane M.D. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 1812-1816Crossref PubMed Scopus (111) Google Scholar) or pJ3M, containing a Myc epitope tag, were used for the transient expression of the cDNAs in COS-7 cells using the DEAE-dextran method. For in vitro binding assays between Reps1 and RalBP1, 1–3 μg of GST-Reps protein bound to 25 μl of glutathione beads were incubated with 500 μl of a COS7 cell lysate derived from one 10-cm dish of semiconfluent cells. The cells had been transiently transfected with Myc-RalBP1 or segments of RalBP1 containing a Myc epitope tag and then lysed in 20 mmTris-HCl (pH 7.5), containing 10 mm MgCl2, 20 mm NaCl, 0.5% Nonidet P-40, and 0.1 mmphenylmethylsulfonyl fluoride and 10 μg/ml aprotinin. After washing beads in binding buffer, the precipitates were run on SDS-PAGE and immunoblotted with anti-Myc monoclonal antibodies, 9E10, followed by incubation with horseradish peroxidase-conjugated secondary antibodies. Blots were visualized by using enhanced chemiluminescence (ECL) reagents (Amersham Corp.). In vitro binding assays between SH3 domains and Reps1 were performed as above, except that 5 μg of GST- SH3 domains (kindly provided by Dr. Bruce Meyer (Harvard Medical School) were substituted for GST-Reps1. For in vivo binding assays between Reps1 and RalBP1, transiently transfected COS7 cells (one 10-cm dish of semiconfluent cells) were lysed in 500 μl of 20 mm Tris-HCl (pH 7.5), containing 10 mm MgCl2, 20 mm NaCl, 0.5% Nonidet P-40, and 0.1 mm phenylmethylsulfonyl fluoride and 10 μg/ml aprotinin. Anti-Glu antibodies (kindly provided by S. Powers, Onyx Pharmaceuticals) were added for 60 min, followed by protein A-Sepharose. After washing the beads with binding buffer, the samples were fractionated by SDS-PAGE. The gels were then blotted with anti-Myc antibodies and then incubated with horseradish-conjugated secondary antibodies. Cell lysates were also run directly on gels and immunoblotted with either anti-Myc or anti-Glu antibodies to verify Reps1 and RalBP1 expression. Blots were visualized as describe above. To identify new functions for RalBP1, the protein was used as bait in the yeast two-hybrid system. A yeast reporter strain, expressing a RalBP1/GAL4 DNA-binding domain fusion, was transformed with a mouse muscle cell cDNA library expressed as fusions with the GAL4 activation domain (17Durfee T. Becherer K. Chen P.-L. Yeh S.-H. Yang Y. Kilourn A.E. Lee W.-H. Elledge S.J. Genes Dev. 1993; 7: 555-569Crossref PubMed Scopus (1300) Google Scholar). From 106 primary transformants, 15 survived the initial histidine selection and only one was also positive for the secondary screen (expression of β-galactosidase) and the tertiary screen (binding to RalBP1 in vitro (see below)). This ∼500-base pair clone was used as a probe to clone additional cDNA sequences by hybridization with a λGT10 cDNA library. Finally, the N-terminal end of the cDNA was cloned by 5′-RACE. One continuous open reading frame was detected that encodes a 743 amino acid protein (Fig. 1 A). The cDNA clone was used as a probe in a Northern blot of RNA isolated from a variety of rat tissues. One major band, with a size of ∼3.5 kilobases, was observed in all tissues examined (data not shown). The highest level of expression was found in kidney and testis. The amino acid sequence encoded by the cDNA was then compared with known proteins. Although this protein was novel, significant sequence similarity (between 38 and 50% identity) was found between amino acids 237 and 298 and the EH domains present in a variety of proteins (20Wong W.T. Schumacher C. Salcini A.E. Romano A. Castagnino P. Pelicci P.G. Di Fiore P. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 9530-9534Crossref PubMed Scopus (136) Google Scholar). These include the human Eps15 and Eps15-related (Eps15r) proteins, which each contain three EH domains, and S. cerevisiae Pan1 and End3 proteins, which contain two and one EH domains, respectively (Fig. 1, A and B). A putative EF hand resides within many EH domains (see Fig. 1 B), suggesting that they are calcium-binding motifs. Recently it has been shown that the EH domains of Eps15 and Eps15R constitute protein-protein interaction modules that bind to segments of proteins containing the amino acid sequence asparagine-proline-phenylalanine (NPF) (21Salcini A.E. Confalonieri S. Doria M. Santolini E. Tassi E. Minenkova O. Cesareni G. Pelicci P.G. Di Fiore P.P. Genes Dev. 1997; 11: 2239-2249Crossref PubMed Scopus (287) Google Scholar). Thus, one function of Reps may be to interact with a specific protein containing this motif. Based on the possible importance of the EH domain, we have called this RalBP1-binding protein, RalBP1-associatedEps homology protein 1 or Reps1. A linear map containing putative functional domains of Reps1 is shown in Fig.1 C. A fusion protein containing glutathione S-transferase (GST) and the coding sequence of the partial Reps1 cDNA clone first isolated from the yeast two-hybrid system (C-terminal amino acids 599–743) was produced in E. coli. After affinity purification on glutathione beads, the immobilized Reps1 protein was incubated with COS cell lysates transfected with various portions of RalBP1, each containing a Myc epitope at its N terminus. After washing the beads, the bound proteins were fractionated by SDS-PAGE and immunoblotted with anti-Myc antibodies (Fig. 2 A). Bindingin vitro was observed between the C terminus of Reps-1 and full-length RalBP1, but not the N-terminal 500 amino acids of RalBP-1, which contains a basic α-helix, a CDC42/Rac GAP domain, and a Ral binding site (see Fig. 1 C). Binding was also observed between Reps1 and a C-terminal portion (aa 201–647) of RalBP1 containing the Ral binding site and an extended region of predicted α-helix. Thus, Reps1 binds to a region in the C-terminal region of RalBP-1 that is distinct from the binding sites for Ral and CDC42/Rac (see Fig. 1 C) The C-terminal 43 amino acids of Reps1 (aa 700–743) are predicted to exist as a coiled-coil (Fig. 1, Aand C). A GST fusion construct containing these sequences failed to bind to RalBP1 in vitro (data not shown). Thus, although the coiled-coil may participate in binding to RalBP1, it is not sufficient for binding activity. Myc epitope-tagged Reps and Glu epitope-tagged RalBP1 were transfected either alone or together into COS7 cells. Cell lysates were prepared 24 h later, and RalBP1 was immunoprecipitated with anti-Glu antibodies. The immunoprecipitates were fractionated by SDS-PAGE and immunoblotted with anti-Myc antibodies (Fig.2 B). Reps1 protein was clearly detected in RalBP1 immunoprecipitates only when the two proteins were co-expressed. The panels on the left are immunoblots of cell lysates showing that Reps1 and RalBP1 were expressed when the their encoded DNAs were transfected. These results document that Reps1 and RalBP1 can form stable complexes in cells. Eps15 was originally detected because it became tyrosine-phosphorylated in response to EGF. Therefore we tested whether Reps also becomes tyrosine-phosphorylated in response to EGF. COS7 cells were transiently transfected with Myc-Reps1 and then serum starved for 24 h. Duplicate dishes of starved cells were treated with buffer or buffer containing 10 ng/ml EGF for 8 min. Lysates of cells were either run directly on SDS gels and blotted with anti-Myc antibodies to detect Reps1 expression (Fig. 3 A, left) or immunoprecipitated with anti-Myc antibodies. The immunoprecipitates were then fractionated by SDS-PAGE and immunoblotted with anti-Tyr(P) antibodies. Fig. 3 A (right panel) shows an increase in tyrosine-phosphorylated Reps1 in response to EGF stimulation. This tyrosine phosphorylation may occur just proximal to the EH domain, since a single tyrosine phosphorylation consensus site was detected in Reps1 in sequences surrounding tyrosine 236 (see Fig. 1). Like Eps15, Reps1 also contains polyproline segments, which is suggestive of SH3 binding activity (See Fig. 1 A). One motif between amino acids 531 and 540 contains the sequence P-A-V-P-P-R, which matches the consensus sequence P-X-L-P-X-K found in all proteins known to interact with the SH3 domain of the Crk adapter protein (22Schumacher C. Knudsen B.S. Ohuchi T. Di Fiore P.P. Glassman R.H. Hanafusa H. J. Biol. Chem. 1995; 270: 15341-15347Abstract Full Text Full Text PDF PubMed Scopus (81) Google Scholar). A similar motif is capable of binding Grb2. Thus, SH3 binding activity of Reps1 was tested by incubating lysates of cells containing Myc-Reps1 with Sepharose beads containing fusion proteins of GST and the SH3 domains of Crk, Grb2 (N- and C-terminal domains tested individually), Src, and Abl. The beads were washed, run on SDS gels, and blotted with anti-Myc antibodies to detect bound Reps1. Fig.3 B shows complexes between Reps1 and GST-Crk(SH3) and GST-Grb2(N-SH3), but not GST-Grb2(C-SH3), GST-Src(SH3), GST-Abl(SH3), or GST alone. These results suggest that Reps1 may form a complex directly with the EGF receptor through the adapter proteins Crk or Grb2. However, we have been unable to detect such a complex in this cell system (data not shown). A growing body of evidence supports the idea that Ras proteins activate a distinct downstream signaling pathway by binding to and activating Ral-specific nucleotide exchange factors. These findings have stimulated interest in defining the function of Ral GTPases. One potential effector of Ral proteins is RalBP1, a 73-kDa protein that binds specifically to the GTP-bound state of Ral proteins (13Cantor S. Urano T. Feig L.A. Mol Cell. Biol. 1995; 15: 4578-4584Crossref PubMed Scopus (261) Google Scholar, 14Jullien-Flores V. Dorseuil O. Romero F. Letourneur F. Saragosti S. Berger R. Tavitian A. Gacon G. Camonis J.H. J. Biol. Chem. 1995; 270: 22473-22477Abstract Full Text Full Text PDF PubMed Scopus (289) Google Scholar, 15Park S.H. Weinberg R.A. Oncogene. 1995; 11: 2349-2355PubMed Google Scholar). In addition to a Ral binding site, RalBP1 contains a GAP domain that inactivates CDC42 and Rac GTPases. Based on its ability to bind to RalBP1, Reps1 is another potential mediator of Ral function. In vitro data presented here argue that Reps binds to a region of RalBP1 that is distinct from the binding sites for Ral and CDC42/Rac. Moreover, transfection studies show that Reps1 and RalBP1 can interact in vivo, although this remains to be documented for their endogenous cellular counterparts. A clue to the function of Reps1 comes from the presence of an EH domain. EH domains were first detected in Eps15 (23Fazioli F. Minichiello L. Matoskova B. Wong W.T. Di Fiore P.P. Mol. Cell. Biol. 1993; 13: 5814-5828Crossref PubMed Scopus (238) Google Scholar), which contains three tandem EH motifs of ∼70 amino acids at its N terminus (see Fig.1 B). Recent experiments using peptide libraries and expression cloning have revealed that the EH domains of Eps15 and Eps15r function as binding motifs for proteins that contain the amino acid sequence asparagine-proline-phenylalanine (NPF) (21Salcini A.E. Confalonieri S. Doria M. Santolini E. Tassi E. Minenkova O. Cesareni G. Pelicci P.G. Di Fiore P.P. Genes Dev. 1997; 11: 2239-2249Crossref PubMed Scopus (287) Google Scholar). Like other protein-interacting domains, the amino acids neighboring these core sequences were also found to be important and may contribute to binding specificity. Biochemical analysis strongly suggests that Eps15 is involved in receptor-mediated endocytosis in mammalian cells. Eps15 has been detected in the clathrin-coated vesicles, where it is constitutively associated with α-adaptin (24van Delft S. Schumacher C. Hage W. Verkleij A.J. van Bergen en Henegouwen P.M. J. Cell Biol. 1997; 136: 811-821Crossref PubMed Scopus (112) Google Scholar, 25Tebar F. Sorkina T. Sorkin A. Ericsson M. Kirchhausen T. J. Biol. Chem. 1996; 271: 28727-28730Abstract Full Text Full Text PDF PubMed Scopus (214) Google Scholar, 26Benmerah A. Begue B. Dautry-Varsat A. Cerf-Bensussan N. J. Biol. Chem. 1996; 271: 12111-12116Abstract Full Text Full Text PDF PubMed Scopus (166) Google Scholar). Eps15 is also complexed with the light chain of clathrin (24van Delft S. Schumacher C. Hage W. Verkleij A.J. van Bergen en Henegouwen P.M. J. Cell Biol. 1997; 136: 811-821Crossref PubMed Scopus (112) Google Scholar). Finally, Eps15 can bind to the SH3 domain of the Crk adapter molecule, which may promote its association with activated EGF receptors (22Schumacher C. Knudsen B.S. Ohuchi T. Di Fiore P.P. Glassman R.H. Hanafusa H. J. Biol. Chem. 1995; 270: 15341-15347Abstract Full Text Full Text PDF PubMed Scopus (81) Google Scholar, 27Matsuda M. Ota S. Tanimura R. Nakamura H. Matuoka K. Takenawa T. Nagashima K. Kurata T. J. Biol. Chem. 1996; 271: 14468-14472Abstract Full Text Full Text PDF PubMed Scopus (76) Google Scholar). These findings have led to the hypothesis that Eps 15 promotes the association of EGF receptor with newly forming coated vesicles, an early step in the internalization and down-regulation of the receptor. Support for the idea that EH domains, in particular, participate in endocytosis comes from studies on the EH domain yeast proteins End3 and Pan1. S. cerevisiae expressing mutant End3 or Pan1 proteins display defects in both receptor-mediated and fluid phase endocytosis (28Tang H.Y. Munn A. Cai M. Mol. Cell. Biol. 1997; 17: 4294-4304Crossref PubMed Scopus (120) Google Scholar, 29Benedetti H. Raths S. Crausaz F. Riezman H. Mol. Biol. Cell. 1994; 5: 1023-1037Crossref PubMed Scopus (237) Google Scholar). In addition, evidence points to a role of these EH domain proteins in cortical actin cytoskeleton-related processes (28Tang H.Y. Munn A. Cai M. Mol. Cell. Biol. 1997; 17: 4294-4304Crossref PubMed Scopus (120) Google Scholar, 29Benedetti H. Raths S. Crausaz F. Riezman H. Mol. Biol. Cell. 1994; 5: 1023-1037Crossref PubMed Scopus (237) Google Scholar). For example, altering the activity of Pan1 results in an abnormal distribution of the actin cytoskeleton. The presence of an EH domain in Reps1 suggests this protein may also influence endocytosis and/or the actin cytoskeleton. Interestingly, Eps15 and Reps1 have additional features in common. Like Eps15, Reps1 becomes tyrosine-phosphorylated in response to EGF stimulation. Although the site of tyrosine phosphorylation has not been mapped for either protein, both have a single consensus tyrosine phosphorylation immediately N-terminal to an EH domain. Both proteins also have the capacity to bind to the SH3 domain of the adapter protein Crk. This may allow Reps1 to form a complex with the EGF receptor. However, we have not been able to detect such a complex in the cell system we have used. For Eps15, a complex with the EGF receptor has been detected only in cells overexpressing the EGF receptor (24van Delft S. Schumacher C. Hage W. Verkleij A.J. van Bergen en Henegouwen P.M. J. Cell Biol. 1997; 136: 811-821Crossref PubMed Scopus (112) Google Scholar). Finally, both Reps and Eps15 have a coiled-coil region. In Eps15 this region is in the middle of the protein, and appears to promote homo-oligomerization (30Tebar F. Confalonieri S. Carter R.E. Di Fiore P.P. Sorkin A. J. Biol. Chem. 1997; 272: 15413-15418Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar). In Reps1, the coiled-coil is at the extreme C terminus. It cannot bind RalBP1 on its own, raising the possibility that Reps1 may also homodimerize. A major distinction between Reps1 and Eps15 is that the C terminus of the latter contains repeats of aspartate, proline, and phenylalanine, which are responsible for the constitutive association of Eps15 with clathrin-coated vesicles (31Iannolo G. Salcini A.E. Gaidarov I. Goodman O.B. Baulida J. Carpenter G. Pelicci P.G. Di Fiore P.P. Keen J.H. Cancer Res. 1997; 57: 240-245PubMed Google Scholar). In contrast, Reps1 contains a RalBP1 binding site at a comparable region of the protein. Presumably, this leads to the regulated localization of Reps1 to a site in the cell where Ral exists. Ral proteins have been detected in plasma membrane fractions, where they are thought to become activated by Ras-induced activation of Ral-specific nucleotide exchange factors. 2R. Emkey and L. A. Feig, unpublished observations. However, a majority of Ral proteins are found in intracellular vesicles, including clathrin coated vesicles as well as exocytic vesicles (32Feig L.A. Emkey L.A. McCormick F. Lacal J.C. The ras Superfamily of GTPases. CRC Press, London1993: 247-258Google Scholar, 33Bielinski D.F. Pyun N.Y. Linko-Stentz K. Macara I. Fine R.E. Biochim. Biophys. Acta. 1993; 1151: 246-256Crossref PubMed Scopus (60) Google Scholar). Thus, Reps1 may function at the cell surface or in vesicles. What does this imply about the function of Reps? Based on the information gained from experiments reported here, and previous work on Ral GTPases, a model of potential protein-protein interactions involving Reps1 is shown in Fig. 4. EGF receptor may influence Reps1 in two ways. First, EGF receptor activation leads to the tyrosine phosphorylation of Reps1. Like Eps15, this tyrosine phosphorylation may be promoted by an adapter protein that connects the kinase to its substrate. Moreover, the site of tyrosine phosphorylation on both proteins may be directly proximal to the EH domain. Thus, for both proteins tyrosine phosphorylation may influence EH domain function directly by altering its activity or indirectly by producing a docking site for an SH2 domain protein that can interact with the EH domain. EGF receptor stimulation also leads to the activation of Ras, which can activate Ral and lead to the association of Ral with RalBP1. In this way, a signaling complex connecting EGF receptor, Ral, RalBP1 and tyrosine-phosphorylated Reps1 may be promoted (see Fig. 4). Since Ral has been shown to be constitutively associated with PLD1 (10Jiang H. Luo J.-Q. Urano T. Lu Z. Foster D.A. Feig L.A. Nature. 1995; 378: 409-412Crossref PubMed Scopus (247) Google Scholar, 11Luo J.-Q. Liu X. Hammond S.M. Colley W.C. Feig L.A. Frohman M.A. Morris A.J. Foster D.A. Biochem. Biophys. Res. Commun. 1997; 235: 854-859Crossref PubMed Scopus (79) Google Scholar), this enzyme may also be part of this signaling complex. Interestingly, the known biochemical activities of these signaling molecules are consistent with their participation, along with the EH domain of Reps1, in the regulation of endocytosis and/or the cytoskeleton. For example, RalBP1 is known to be a GAP for CDC42 and Rac. Thus, it has the capacity to inhibit these two actin-regulating GTPases. Since Rac has also been shown to negatively influence receptor-mediated endocytosis (34Lamaze C. Chuang T.H. Terlecky L.J. Bokoch G.M. Schmid S.L. Nature. 1996; 382: 177-179Crossref PubMed Scopus (331) Google Scholar), RalBP1 could have a positive influence on this process. Furthermore, a growing body of evidence supports a role for phospholipase D in the promotion of vesicle budding, possibly through its ability to enhance the production of phosphatidic acid (35Ktistakis N.T. Brown H.A. Waters M.G. Sternweis P.C. Roth M.G. J. Cell Biol. 1996; 134: 295-306Crossref PubMed Scopus (329) Google Scholar, 36Bi K. Roth M.G. Ktistakis N.T. Curr. Biol. 1997; 7: 301-307Abstract Full Text Full Text PDF PubMed Scopus (153) Google Scholar, 37Chen Y.G. Siddhanta A. Austin C.D. Hammond S.M. Sung T.C. Frohman M.A. Morris A.J. Shields D. J. Cell Biol. 1997; 138: 495-504Crossref PubMed Scopus (242) Google Scholar). Future studies will attempt to identify proteins that interact with the Reps1 EH domain. Based on studies on the EH domain of Eps15, these proteins will contain NPF motifs. Their biochemical activities may yield insight into the function of both EGF receptor and Ral GTPase signaling mechanisms." @default.
• W2026403140 created "2016-06-24" @default.
• W2026403140 creator A5001962229 @default.
• W2026403140 creator A5022175836 @default.
• W2026403140 creator A5027126973 @default.
• W2026403140 creator A5042852320 @default.
• W2026403140 date "1997-12-01" @default.
• W2026403140 modified "2023-10-03" @default.
• W2026403140 title "An Eps Homology (EH) Domain Protein That Binds to the Ral-GTPase Target, RalBP1" @default.
• W2026403140 cites W1601647648 @default.
• W2026403140 cites W1976331372 @default.
• W2026403140 cites W1978936325 @default.
• W2026403140 cites W1982681215 @default.
• W2026403140 cites W1985670865 @default.
• W2026403140 cites W1989839956 @default.
• W2026403140 cites W1996376778 @default.
• W2026403140 cites W1997878751 @default.
• W2026403140 cites W2003935644 @default.
• W2026403140 cites W2007375100 @default.
• W2026403140 cites W2012189464 @default.
• W2026403140 cites W2017550542 @default.
• W2026403140 cites W2024645073 @default.
• W2026403140 cites W2028643767 @default.
• W2026403140 cites W2032554631 @default.
• W2026403140 cites W2042013644 @default.
• W2026403140 cites W2066791280 @default.
• W2026403140 cites W2078948761 @default.
• W2026403140 cites W2079286074 @default.
• W2026403140 cites W2080731964 @default.
• W2026403140 cites W2084845518 @default.
• W2026403140 cites W2093269765 @default.
• W2026403140 cites W2095939432 @default.
• W2026403140 cites W2115612586 @default.
• W2026403140 cites W2117019496 @default.
• W2026403140 cites W2118211098 @default.
• W2026403140 cites W2125144482 @default.
• W2026403140 cites W2139868649 @default.
• W2026403140 cites W2142946131 @default.
• W2026403140 cites W214799791 @default.
• W2026403140 cites W2152741987 @default.
• W2026403140 cites W2153604383 @default.
• W2026403140 cites W2158177598 @default.
• W2026403140 cites W2323266789 @default.
• W2026403140 cites W35071699 @default.
• W2026403140 doi "https://doi.org/10.1074/jbc.272.50.31230" @default.
• W2026403140 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9395447" @default.
• W2026403140 hasPublicationYear "1997" @default.
• W2026403140 type Work @default.
• W2026403140 sameAs 2026403140 @default.
• W2026403140 citedByCount "121" @default.
• W2026403140 countsByYear W20264031402012 @default.
• W2026403140 countsByYear W20264031402013 @default.
• W2026403140 countsByYear W20264031402014 @default.
• W2026403140 countsByYear W20264031402015 @default.
• W2026403140 countsByYear W20264031402016 @default.
• W2026403140 countsByYear W20264031402017 @default.
• W2026403140 countsByYear W20264031402018 @default.
• W2026403140 countsByYear W20264031402019 @default.
• W2026403140 countsByYear W20264031402020 @default.
• W2026403140 countsByYear W20264031402021 @default.
• W2026403140 countsByYear W20264031402023 @default.
• W2026403140 crossrefType "journal-article" @default.
• W2026403140 hasAuthorship W2026403140A5001962229 @default.
• W2026403140 hasAuthorship W2026403140A5022175836 @default.
• W2026403140 hasAuthorship W2026403140A5027126973 @default.
• W2026403140 hasAuthorship W2026403140A5042852320 @default.
• W2026403140 hasBestOaLocation W20264031401 @default.
• W2026403140 hasConcept C104317684 @default.
• W2026403140 hasConcept C165525559 @default.
• W2026403140 hasConcept C167625842 @default.
• W2026403140 hasConcept C185592680 @default.
• W2026403140 hasConcept C207332259 @default.
• W2026403140 hasConcept C2779315201 @default.
• W2026403140 hasConcept C515207424 @default.
• W2026403140 hasConcept C55493867 @default.
• W2026403140 hasConcept C86803240 @default.
• W2026403140 hasConcept C95444343 @default.
• W2026403140 hasConceptScore W2026403140C104317684 @default.
• W2026403140 hasConceptScore W2026403140C165525559 @default.
• W2026403140 hasConceptScore W2026403140C167625842 @default.
• W2026403140 hasConceptScore W2026403140C185592680 @default.
• W2026403140 hasConceptScore W2026403140C207332259 @default.
• W2026403140 hasConceptScore W2026403140C2779315201 @default.
• W2026403140 hasConceptScore W2026403140C515207424 @default.
• W2026403140 hasConceptScore W2026403140C55493867 @default.
• W2026403140 hasConceptScore W2026403140C86803240 @default.
• W2026403140 hasConceptScore W2026403140C95444343 @default.
• W2026403140 hasIssue "50" @default.
• W2026403140 hasLocation W20264031401 @default.
• W2026403140 hasOpenAccess W2026403140 @default.
• W2026403140 hasPrimaryLocation W20264031401 @default.
• W2026403140 hasRelatedWork W1668278268 @default.
• W2026403140 hasRelatedWork W1967262983 @default.
• W2026403140 hasRelatedWork W1985953812 @default.
• W2026403140 hasRelatedWork W2010688658 @default.
• W2026403140 hasRelatedWork W2021047807 @default.
• W2026403140 hasRelatedWork W2026403140 @default.
• W2026403140 hasRelatedWork W2149491013 @default.

• next